Benign Prostate Hyperplasia

  • Schwab M
N/ACitations
Citations of this article
7Readers
Mendeley users who have this article in their library.
Get full text

Abstract

Modern methods of Benign Prostate Hyperplasia (BPH) induction in rats are based on two main approaches: by an increase of testosterone or prolactin levels in blood. First of them is realized by testosterone injections or by subcutaneous solid implants that serves as androgen repository. The second one stimulates prolactin overproduction in pituitary gland by sulpiride, a selective antagonist at dopamine D2 receptors and usually used as a neuroleptic drug. Comparison of morphological, functional, histological, cytological and molecular-biological peculiarities of human and rat prostate was performed to evaluate adequacy and goodness of different BPH models. According to this analysis, most parameters of human prostate hyperplasia are reproduced in the lateral lobe prostate of rat treated by sulpiride. предстательной железы (ДГПЖ) у крыс путем повышения содержания в крови тестостерона или пролактина. Проведено сравнение анатомических, гистологических, цитологических, функциональных и молекулярно-генетических особенностей предстательной железы (ПЖ) человека и крысы, а также особенности их доброкачественной пролиферации с целью определения границ экстраполяции модели на человека. Показано, что по большинству рассмотренных параметров ДГПЖ человека наиболее адекватно воспроизводится с помощью сульпирида в латеральной доле ПЖ крысы.

Cite

CITATION STYLE

APA

Schwab, M. (2014). Benign Prostate Hyperplasia. In Encyclopedia of Cancer (pp. 1–2). Springer Berlin Heidelberg. https://doi.org/10.1007/978-3-642-27841-9_6779-2

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free